Results 131 to 140 of about 44,493 (220)

Massive Recurrent Parotid Carcinoma in a 90-Year-Old Patient: A Case Report and Review of Management Strategies. [PDF]

Cureus
Banana Y, El Mahjoubi A, Sbai A, Benfadil D, Lachkar A.   +4 more
europepmc   +1 more source

Ten‐Year Outcome of a Patient With Concurrent Pelvic Myeloid Sarcoma and Underlying Chronic Myeloid Leukaemia in Chronic Phase: A Case Report and Literature Review

Cancer Reports, Volume 9, Issue 3, March 2026.
ABSTRACT Background Myeloid sarcoma is a rare solid tumour of immature myeloid precursors occurring in an extramedullary site. It often presents significant diagnostic and therapeutic challenges to clinical haematologists. Case We describe a previously healthy patient who presented simultaneously with hyperleucocytic chronic myeloid leukaemia in ...
Kar Ying Yong, Soo How Lim, Lee Gong Lau, Lee Ping Chew   +3 more
wiley   +1 more source

Age-related changes in the parotid gland: a computed tomography-based radiomics study. [PDF]

Quant Imaging Med Surg
Lin Z, Shi Y, Hu H, You M.
europepmc   +1 more source

Patient‐Reported Dysphagia and Swallowing‐Related Quality of Life up to 10 Years After (Chemo)radiotherapy for Head and Neck Cancer: A Cross‐Sectional Study

Head &Neck, Volume 48, Issue 3, Page 733-746, March 2026.
ABSTRACT Background This study sought to better understand patient‐reported dysphagia and swallowing‐related quality of life (swQOL) in patients 6 months to 10 years following definitive (chemo)radiotherapy for head and neck cancer (HNC). Methods In this cross‐sectional study, self‐reported dysphagia was assessed with the Eating Assessment Tool (EAT‐10)
Jacqui J. Frowen, Allison Drosdowsky, Tsien F. Fua, Lachlan J. McDowell, Karla Gough   +4 more
wiley   +1 more source

Clinicopathological characteristics and surgical outcomes of pleomorphic adenoma of salivary glands among Sudanese patients. [PDF]

BMC Oral Health
Osman T, Eltohami Y, Osman Y.
europepmc   +1 more source

Neoadjuvant Immunotherapy for Periauricular Cutaneous Squamous Cell Carcinoma

Head &Neck, Volume 48, Issue 3, Page 837-842, March 2026.
ABSTRACT Background The standard‐of‐care for advanced periauricular cutaneous squamous cell carcinoma (pCSCC) is surgery and adjuvant radiation therapy. Neoadjuvant immunotherapy recently demonstrated high pathologic response rates in patients with resectable pCSCC.
David Z. Allen, Neil Gross, Marc‐Elie Nader, Renata Ferrarotto, Moran Amit, Priyadharsini Nagarajan, Paul Gidley   +6 more
wiley   +1 more source

Histopathological and ultrastructure alterations in tongue and parotid tissues of rats in consequence to long-term alcohol intoxication and ameliorative role of 10-dehydrogingerdione. [PDF]

BMC Oral Health
Hassabou NF, Elseweidy MM, Farag AF.
europepmc   +1 more source

Surgical Management of Pediatric Lymphatic Malformations: A Cross‐Sectional Study of Outcomes, Complications, and Recurrence at a Tertiary Care Center

Health Science Reports, Volume 9, Issue 3, March 2026.
ABSTRACT Background and Aims Lymphatic malformations (LMs) are congenital anomalies of the lymphatic system, frequently affecting pediatric populations. While complete surgical excision remains a primary therapeutic option, factors influencing outcomes, including lesion location and age at intervention, remain inadequately explored.
Nashwa Mohammed Al Nwaijie, Ahmad Alkheder, Adel Azar, Basem Alarsan Alyaseen, Abdulmajeed Yousfan   +4 more
wiley   +1 more source

Synchronous mucoepidermoid carcinoma of sublingual gland and pleomorphic adenoma of palatal gland-a case report and literature review. [PDF]

BMC Oral Health
Kang K, Wu Y, Liu W, Liu K, Sha T.
europepmc   +1 more source

Safety of Baricitinib for the Treatment of Atopic Dermatitis in Adults Over a Median of 1.6 and up to 4.6 Years Treatment: Final Integrated Analysis of Eight Clinical Trials

JEADV Clinical Practice, Volume 5, Issue 1, Page 67-74, March 2026.
ABSTRACT Background Baricitinib is a selective Janus kinase (JAK)1/JAK2 inhibitor approved in more than 70 countries for the treatment of moderate‐to‐severe atopic dermatitis (AD) in adults, and in over 30 countries for adolescents and children from age 2 years with moderate‐to‐severe AD, who are candidates for systemic therapy.
Antonio Costanzo, Antonio Torrelo, Eric L. Simpson, Marjolein De Bruin‐Weller, Diamant Thaçi, Norito Katoh, Silvia Sabatino, Andrew Buchanan, Kasia Morawska, Samuel Ogwu, Karen Denning, Jonathan I. Silverberg   +11 more
wiley   +1 more source